IvanLieberburgMD

Diabetes, Lipid Metabolism

Professor of Medicine, University of California, San Francisco. Managing Director, Boxer Capital of the Tavistock Group. Director, Adamas Pharmaceuticals, Inc.

Join to view full profile

Dr. Lieberburg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lieberburg's full profile

Already have an account?

Office
440 Stevens Ave
Suite 100
Solana Beach, CA 92075
Phone+1 650-302-8344

Fax+1 858-400-3101

Education & Training

University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1984
University of California (San Francisco)Residency, Internal Medicine, 1980 - 1982
University of Miami Leonard M. Miller School of MedicineClass of 1980
Rockefeller University HospitalPost-Doctoral Fellowship, 1976 - 1978
Rockefeller UniversityPh.D., Neurobiology, 1971 - 1976
Cornell UniversityAB, Biology, 1967 - 1971

Certifications & Licensure

FL State Medical License 1989 - Present
CA State Medical License 1981 - 2021
NY State Medical License 1984 - 2011

Awards, Honors, & Recognition

Kaiser Teaching Award UCSF, 2009
Neuroscience Fellow McKnight Foundation, 1985-1987
Scholar Hartford Foundation, 1984-1987
National Research Service Awardee NIH, 1982-1984
Scholar Public Health Corps, 1978-1980
Join now to see all

Publications & Presentations

PubMed

1554 citations
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.
Frederique Bard, Catherine Cannon, Robin Barbour, Rae Lyn Burke, Dora Games
Nature Medicine. 2000-08-01
1449 citations
Amyloid β-peptide is produced by cultured cells during normal metabolism
Christian Haass, Michael G. Schlossmacher, Albert Y. Hung, Carmen Vigo-Pelfrey, A Mellon
Nature. 1992-09-24
999 citations
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
Martin Citron, David Westaway, Weiming Xia, George A. Carlson, Thekla S. Diehl
Nature Medicine. 1997-01-01

Press Mentions

Adamas Announces Changes to Its Board of Directors with the Appointment of Spyros Papapetropoulos and the Retirement of Ivan LieberburgNovember 23rd, 2020